Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial
PaperCitations, authors & open-access status
Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 144 citations, 2013 year and bronze oa status.
144
Citations
2013
Year
bronze
OA Status